CA2674988C - Epigenetic change in the ndrg4 gene and cancer - Google Patents

Epigenetic change in the ndrg4 gene and cancer Download PDF

Info

Publication number
CA2674988C
CA2674988C CA2674988A CA2674988A CA2674988C CA 2674988 C CA2674988 C CA 2674988C CA 2674988 A CA2674988 A CA 2674988A CA 2674988 A CA2674988 A CA 2674988A CA 2674988 C CA2674988 C CA 2674988C
Authority
CA
Canada
Prior art keywords
gene
cancer
sample
ndrg4
osmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2674988A
Other languages
English (en)
French (fr)
Other versions
CA2674988A1 (en
Inventor
Manon Van Engeland
Manon Adriaan De Bruine
Arjan Griffioen
Joost Louwagie
Katja Bierau
Gontran Brichard
Gaetan Otto
Maarten Penning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exact Sciences Corp
Original Assignee
Exact Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37801915&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2674988(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Exact Sciences Corp filed Critical Exact Sciences Corp
Publication of CA2674988A1 publication Critical patent/CA2674988A1/en
Application granted granted Critical
Publication of CA2674988C publication Critical patent/CA2674988C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CA2674988A 2007-01-09 2008-01-09 Epigenetic change in the ndrg4 gene and cancer Active CA2674988C (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US87933207P 2007-01-09 2007-01-09
US60/879,332 2007-01-09
GBGB0700374.2A GB0700374D0 (en) 2007-01-09 2007-01-09 NDRG family methylation markers
GB0700374.2 2007-01-09
US96013007P 2007-09-17 2007-09-17
US60/960,130 2007-09-17
US97826107P 2007-10-08 2007-10-08
US60/978,261 2007-10-08
PCT/GB2008/000056 WO2008084219A1 (en) 2007-01-09 2008-01-09 Epigenetic change in selected genes and cancer

Publications (2)

Publication Number Publication Date
CA2674988A1 CA2674988A1 (en) 2008-07-17
CA2674988C true CA2674988C (en) 2024-04-23

Family

ID=37801915

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2674988A Active CA2674988C (en) 2007-01-09 2008-01-09 Epigenetic change in the ndrg4 gene and cancer

Country Status (7)

Country Link
US (6) US8969046B2 (enExample)
EP (3) EP2650377B1 (enExample)
JP (2) JP5721950B2 (enExample)
CN (1) CN101680025A (enExample)
CA (1) CA2674988C (enExample)
GB (1) GB0700374D0 (enExample)
WO (1) WO2008084219A1 (enExample)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7485420B2 (en) * 2003-08-14 2009-02-03 Case Western Reserve University Methods and compositions for detecting colon cancers
US8415100B2 (en) 2003-08-14 2013-04-09 Case Western Reserve University Methods and compositions for detecting gastrointestinal and other cancers
US12366585B2 (en) 2006-05-18 2025-07-22 Caris Mpi, Inc. Molecular profiling of tumors
GB0700374D0 (en) 2007-01-09 2007-02-14 Oncomethylome Sciences S A NDRG family methylation markers
WO2008100913A2 (en) * 2007-02-12 2008-08-21 The Johns Hopkins University Early detection and prognosis of colon cancers
NZ596545A (en) 2007-09-17 2013-05-31 Glaxosmithkline Biolog Sa Improved detection of mage-a expression
US8673555B2 (en) 2008-02-15 2014-03-18 Mayo Foundation For Medical Education And Research Detecting neoplasm
EP2250287B1 (en) * 2008-02-19 2013-09-18 MDxHealth SA Detection and prognosis of lung cancer
CA2718092C (en) * 2008-03-21 2019-03-19 Oncomethylome Sciences S.A. Detection and prognosis of cervical cancer
US20110160080A1 (en) 2008-05-14 2011-06-30 Chang Sherman H Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis
EP2329040B1 (en) * 2008-09-22 2017-10-11 ADVPharma, Inc. Molecular markers for lung and colorectal carcinomas
WO2010089538A2 (en) 2009-02-03 2010-08-12 Oncomethylome Sciences Sa Methods of detecting colorectal cancer
WO2010102823A1 (en) * 2009-03-13 2010-09-16 Oncomethylome Sciences Sa Novel markers for bladder cancer detection
CA2779223A1 (en) 2009-10-27 2011-05-12 Caris Mpi, Inc. Molecular profiling for personalized medicine
EP2354242A1 (en) * 2010-02-03 2011-08-10 Epiontis GmbH Assay for determining the type and/or status of a cell based on the epigenetic pattern and the chromatin structure
EP2553463B1 (en) 2010-03-26 2017-05-03 Hongzhi Zou Methods and materials for detecting colorectal neoplasm
WO2011135058A2 (en) 2010-04-30 2011-11-03 Mdxhealth Sa Methods for detecting epigenetic modifications
US9309565B2 (en) * 2010-05-14 2016-04-12 Life Technologies Corporation Karyotyping assay
JP6222202B2 (ja) * 2010-07-05 2017-11-01 ソニー株式会社 生体情報処理方法および装置、並びに記録媒体
JP5838557B2 (ja) * 2010-07-05 2016-01-06 ソニー株式会社 生体情報処理方法および装置、並びに記録媒体
US8916344B2 (en) 2010-11-15 2014-12-23 Exact Sciences Corporation Methylation assay
US8361720B2 (en) 2010-11-15 2013-01-29 Exact Sciences Corporation Real time cleavage assay
EP3441479B1 (en) * 2011-02-02 2020-09-02 Exact Sciences Development Company, LLC Digital sequence analysis of dna methylation
CN103649298A (zh) * 2011-05-12 2014-03-19 精密科学公司 核酸的分离
US8993341B2 (en) 2011-05-12 2015-03-31 Exact Sciences Corporation Removal of PCR inhibitors
US10308980B2 (en) * 2011-11-04 2019-06-04 Oslo Universitetssykehus Hf Methods and biomarkers for analysis of colorectal cancer
EP2788505B1 (en) * 2011-12-06 2017-08-23 MDxHealth SA Methods of detecting mutations and epigenetic changes
US9744155B2 (en) 2012-03-28 2017-08-29 Ixcela, Inc. IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
CA2874407A1 (en) 2012-05-24 2013-11-28 Fundacio Institut D'investigacio Biomedica De Bellvitge (Idibell) Method for the identification of the origin of a cancer of unknown primary origin by methylation analysis
EP2891720B1 (en) * 2012-08-31 2020-04-08 National Defense Medical Center Method for screening cancer
CN102787174B (zh) * 2012-09-06 2013-08-07 南京大学 胃肠肿瘤发病相关抑癌基因表观突变检测试剂盒及其用途
AU2013355260B2 (en) * 2012-12-04 2019-07-25 Caris Mpi, Inc. Molecular profiling for cancer
EP2971179B1 (en) 2013-03-14 2019-01-09 Mayo Foundation for Medical Education and Research Detecting neoplasm
US9644232B2 (en) 2013-07-26 2017-05-09 General Electric Company Method and device for collection and amplification of circulating nucleic acids
US10253358B2 (en) 2013-11-04 2019-04-09 Exact Sciences Development Company, Llc Multiple-control calibrators for DNA quantitation
EP2886659A1 (en) * 2013-12-20 2015-06-24 AIT Austrian Institute of Technology GmbH Gene methylation based colorectal cancer diagnosis
CN105934520A (zh) * 2014-01-31 2016-09-07 伊克斯塞拉有限公司 作为生物标志物的共价键代谢物
JP2015177745A (ja) * 2014-03-18 2015-10-08 愛知県 肺癌の検査方法
US10301680B2 (en) 2014-03-31 2019-05-28 Mayo Foundation For Medical Education And Research Detecting colorectal neoplasm
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
CN104561258B (zh) * 2014-10-08 2016-08-24 王红卫 一种用于直结肠癌早期诊断的检测试剂盒及其应用
GB201418965D0 (enExample) 2014-10-24 2014-12-10 Ospedale San Raffaele And Fond Telethon
EP3225630B1 (en) 2014-11-27 2021-05-12 Public University Corporation Yokohama City University Method and reagent for detecting ovarian clear cell adenocarcinoma
US9984201B2 (en) 2015-01-18 2018-05-29 Youhealth Biotech, Limited Method and system for determining cancer status
US10030272B2 (en) 2015-02-27 2018-07-24 Mayo Foundation For Medical Education And Research Detecting gastrointestinal neoplasms
WO2016160454A1 (en) 2015-03-27 2016-10-06 Exact Sciences Corporation Detecting esophageal disorders
JP2016192909A (ja) * 2015-03-31 2016-11-17 シスメックス株式会社 胃癌に関する情報の取得方法、ならびに胃癌に関する情報を取得するためのマーカーおよび胃癌検出用キット
JP6871926B2 (ja) 2015-08-31 2021-05-19 マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチＭａｙｏ Ｆｏｕｎｄａｔｉｏｎ ｆｏｒ Ｍｅｄｉｃａｌ Ｅｄｕｃａｔｉｏｎ ａｎｄ Ｒｅｓｅａｒｃｈ 胃の新生物を検出すること
HK1258397A1 (zh) 2015-09-09 2019-11-08 Drawbridge Health, Inc. 用於样品收集、稳定化和保存的系统、方法和装置
CN105177163B (zh) * 2015-10-21 2018-04-13 山东大学齐鲁医院 一种用于宫颈癌早期筛查的试剂盒
CA3002196C (en) 2015-10-30 2024-05-14 Exact Sciences Development Company, Llc Multiplex amplification detection assay and isolation and detection of dna from plasma
CN109153993B (zh) 2016-04-14 2023-02-17 梅约医学教育与研究基金会 检测胰腺高度异型增生
US10370726B2 (en) 2016-04-14 2019-08-06 Mayo Foundation For Medical Education And Research Detecting colorectal neoplasia
AU2017260630B2 (en) 2016-05-05 2023-07-13 Exact Sciences Corporation Detection of lung neoplasia by analysis of methylated DNA
WO2017210341A1 (en) 2016-05-31 2017-12-07 The Regents Of The University Of California Methods for evaluating, monitoring, and modulating aging process
CN106119361B (zh) * 2016-06-28 2020-01-07 宁波思锐生物科技有限公司 用于胃癌早期诊断及预后评估的ndrg4基因甲基化检测的试剂盒及其应用
CN106011263B (zh) * 2016-06-28 2020-01-07 宁波大学 用于检测与胃癌相关的ndrg4基因甲基化程度的试剂盒及其应用
EP3481941A4 (en) 2016-07-06 2020-04-15 Youhealth Biotech, Limited METHYLIZATION MARKERS FOR BREAST AND OVARIAL CANCER AND THEIR USE
US10093986B2 (en) 2016-07-06 2018-10-09 Youhealth Biotech, Limited Leukemia methylation markers and uses thereof
WO2018009705A1 (en) 2016-07-06 2018-01-11 Youhealth Biotech, Limited Liver cancer methylation markers and uses thereof
EP3481403B1 (en) 2016-07-06 2022-02-09 Youhealth Biotech, Limited Solid tumor methylation markers and uses thereof
WO2018009696A1 (en) 2016-07-06 2018-01-11 Youhealth Biotech, Limited Colon cancer methylation markers and uses thereof
US20190241970A1 (en) * 2016-07-08 2019-08-08 Hanumat Co., Ltd. Method for determining likelihood of colorectal cancer development
CN106521006A (zh) * 2016-12-27 2017-03-22 刘鹏飞 Ndrg4基因甲基化检测用试剂体系和试剂盒及其应用
SG10201911879UA (en) 2017-01-10 2020-01-30 Drawbridge Health Inc Devices, systems, and methods for sample collection
CN108300783A (zh) * 2017-01-11 2018-07-20 上海易毕恩基因科技有限公司 用于筛选肠癌和/或胃癌的基因标志物的方法、用该方法筛选的基因标志物及其用途
AU2018211956B2 (en) 2017-01-27 2024-06-20 Exact Sciences Corporation Detection of colon neoplasia by analysis of methylated DNA
US10934592B2 (en) 2017-02-28 2021-03-02 Mayo Foundation For Medical Education And Research Detecting prostate cancer
BR112019018272A2 (pt) 2017-03-02 2020-07-28 Youhealth Oncotech, Limited marcadores metilação para diagnosticar hepatocelular carcinoma e câncer
WO2018220151A1 (en) * 2017-06-02 2018-12-06 Verhaert Peter Dominiek Emiel Maria Mass spectrometry histochemistry of peptides from formaldehyde-fixed, paraffin-embedded tissue
CN107177679A (zh) * 2017-06-07 2017-09-19 北京呈诺医学科技有限公司 一种检测食管鳞癌相关基因tfpi2和hspb2启动子甲基化程度的试剂盒
WO2018237327A1 (en) 2017-06-22 2018-12-27 Triact Therapeutics, Inc. Methods of treating glioblastoma
IT201700072650A1 (it) * 2017-06-28 2018-12-28 Univ Degli Studi Cagliari Metodo per rilevare e/o per la prognosi di neoplasie del colon-retto
EP3687501A4 (en) 2017-09-29 2021-06-23 Triact Therapeutics, Inc. INIPARIB FORMULATIONS AND THEIR USES
CN111742062B (zh) 2017-10-06 2023-11-17 优美佳肿瘤技术有限公司 用于诊断癌症的甲基化标志物
KR102052089B1 (ko) * 2017-11-22 2019-12-05 연세대학교 산학협력단 유전자의 CpG 메틸화 변화를 이용한 간암의 위험도를 평가하는 방법
AU2018374176B2 (en) 2017-11-30 2024-12-12 Exact Sciences Corporation Detecting breast cancer
US10648025B2 (en) 2017-12-13 2020-05-12 Exact Sciences Development Company, Llc Multiplex amplification detection assay II
US11976332B2 (en) 2018-02-14 2024-05-07 Dermtech, Inc. Gene classifiers and uses thereof in non-melanoma skin cancers
CN111989407B (zh) 2018-03-13 2024-10-29 格里尔公司 异常的片段检测及分类
CN108460247B (zh) * 2018-03-29 2022-06-07 上海锐翌生物科技有限公司 基于kras和ndrg4基因确定结直肠肿瘤细胞的方法和系统
CA3302676A1 (en) 2018-04-02 2026-05-13 Grail, Inc. Methylation markers and targeted methylation probe panels
US20210214797A1 (en) * 2018-06-01 2021-07-15 Geneoscopy, Llc Detection method
CN108707667B (zh) * 2018-06-01 2021-10-26 安徽达健医学科技有限公司 一种用于结直肠癌早期诊断的试剂盒及其使用方法
CN108796078B (zh) * 2018-06-05 2022-07-26 苏州唯善生物科技有限公司 一种用于消化道癌诊断、检测或筛查的引物和探针组
CN108977543B (zh) * 2018-08-06 2021-12-14 上海锐翌生物科技有限公司 一种基于联合检测sdc2和sfrp2基因甲基化水平的结直肠癌早期诊断试剂
US11441182B2 (en) * 2018-08-08 2022-09-13 Virginia Commonwealth University Multiplexed and recyclable single-molecule sensors for quantitative analysis of nucleic-acid biomarkers
EP3856903A4 (en) 2018-09-27 2022-07-27 Grail, LLC METHYLATION MARKER AND TARGETED METHYLATION PROBE PANEL
EP3867405A4 (en) 2018-10-17 2022-07-20 The University of Queensland EPIGENETIC BIOMARKER AND USES THEREOF
KR20210111254A (ko) 2018-11-30 2021-09-10 캐리스 엠피아이, 아이엔씨. 차세대 분자 프로파일링
EP3899953A1 (en) 2018-12-21 2021-10-27 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free-dna samples
CA3127329A1 (en) 2019-01-24 2020-07-30 Mayo Foundation For Medical Education And Research Detecting endometrial cancer
US11041847B1 (en) 2019-01-25 2021-06-22 Ixcela, Inc. Detection and modification of gut microbial population
CA3134936A1 (en) 2019-03-26 2020-10-01 Dermtech, Inc. Novel gene classifiers and uses thereof in skin cancers
CN109943638A (zh) * 2019-05-08 2019-06-28 湖南百伯基因技术有限公司 一种检测ndrg4、sdc2和bmp3基因甲基化的引物探针组合及其应用和试剂盒
US11396679B2 (en) 2019-05-31 2022-07-26 Universal Diagnostics, S.L. Detection of colorectal cancer
CN110283911A (zh) * 2019-06-28 2019-09-27 四川沃文特生物技术有限公司 用于粪便样本进行早期结直肠癌基因甲基化检测的引物对和探针及试剂盒
CN110343764B (zh) * 2019-07-22 2020-05-26 武汉艾米森生命科技有限公司 检测结直肠癌相关基因甲基化的检测试剂的应用和试剂盒
US11427874B1 (en) 2019-08-26 2022-08-30 Epi One Inc. Methods and systems for detection of prostate cancer by DNA methylation analysis
JP7799607B2 (ja) 2019-10-31 2026-01-15 マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ 卵巣癌の検出
US11898199B2 (en) 2019-11-11 2024-02-13 Universal Diagnostics, S.A. Detection of colorectal cancer and/or advanced adenomas
IL293489A (en) 2019-12-02 2022-08-01 Caris Mpi Inc predictor of pan-cancer platinum response
US20230049979A1 (en) * 2020-02-06 2023-02-16 OncoHost Ltd. Machine learning prediction of therapy response
MX2022009999A (es) 2020-02-14 2023-01-19 Caris Mpi Inc Puntuacion de prevalencia genomica panomica.
CN111549129B (zh) * 2020-03-30 2023-08-29 宁波美康盛德医学检验所有限公司 用于检测胃癌的试剂盒及其应用
WO2021222828A1 (en) * 2020-04-30 2021-11-04 Guardant Health, Inc. Methods for sequence determination using partitioned nucleic acids
WO2021228418A1 (en) 2020-05-15 2021-11-18 Universal Diagnostics, S.L. Methods and systems for identifying methylation biomarkers
EP4150121A1 (en) 2020-06-30 2023-03-22 Universal Diagnostics, S.A. Systems and methods for detection of multiple cancer types
CN113278693A (zh) * 2020-07-29 2021-08-20 上海吉凯医学检验所有限公司 早期结直肠癌和腺瘤的dna甲基化标志物、检测其的方法及其应用
CN112941162A (zh) * 2020-12-30 2021-06-11 昆明理工大学 一种dna端粒长度和基因甲基化程度相关性的检测方法
WO2022192510A1 (en) * 2021-03-10 2022-09-15 University Of Cincinnati Epigenetic quantification using dna hybridization-based single-molecule immunofluorescent imaging
CN113234821B (zh) * 2021-04-29 2022-09-16 北京艾克伦医疗科技有限公司 鉴定食管癌状态的方法和试剂盒
EP4320276B1 (en) * 2021-05-14 2025-04-23 Universal Diagnostics S.A. Methods for disease detection
TW202307218A (zh) * 2021-05-14 2023-02-16 西班牙商通用診斷公司 用於疾病偵測的方法
IL311764A (en) 2021-09-30 2024-05-01 Tivenix Sa A method for diagnosing and predicting progression of neurodegenerative diseases or disorders
US20260110036A1 (en) * 2022-06-17 2026-04-23 Korea Research Institute Of Bioscience And Biotechnology Marker for prognosis of diffuse type gastric cancer and treatment target
CN117343992A (zh) * 2022-06-29 2024-01-05 广州市基准医疗有限责任公司 一种多基因合并荧光通道检测的方法
CN117385028A (zh) * 2022-07-04 2024-01-12 江苏鹍远生物科技股份有限公司 结直肠癌特异性甲基化标志物及其应用
US12606872B2 (en) 2022-11-16 2026-04-21 Universal Diagnostics, S.A. Methods for stratification and early detection of advanced adenoma and/or colorectal cancer using DNA methylation markers
TWI839307B (zh) * 2023-05-06 2024-04-11 華聯生物科技股份有限公司 利用電腦評估肝癌患者治療後病變進展及預後的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1423528T3 (da) * 2000-09-01 2008-05-13 Epigenomics Ag Fremgangsmåde til bestemmelse af methyleringsgraden af bestemte cytosiner i genomisk DNA i sekvenskonteksten 5-CPG-3
CN1650033A (zh) * 2002-03-07 2005-08-03 约翰霍普金斯大学医学院 针对与癌症相关的表观遗传学沉默基因的基因组筛选
CA2519456A1 (en) * 2003-03-17 2004-09-30 Michael G. Goggins Aberrantly methylated genes in pancreatic cancer
WO2005001140A2 (en) * 2003-06-23 2005-01-06 Epigenomics Ag Methods and nucleic acids for the analysis of colon cell proliferative disorders
JP2005110645A (ja) * 2003-09-16 2005-04-28 National Cancer Center-Japan 哺乳動物由来の検体の癌化度を評価する方法
US20080118926A1 (en) 2004-12-13 2008-05-22 National University Corporation Okayama University Method For Detecting Methylation In Genes And Method For Examining Neoplasm Through Detecting Methylation In Genes
JP2006166732A (ja) * 2004-12-13 2006-06-29 Okayama Univ 消化器中の新生物の検出方法
WO2006084078A2 (en) 2005-02-02 2006-08-10 Raven Biotechnologies, Inc. Jam-3 and antibodies that bind thereto
ATE547537T1 (de) * 2005-04-15 2012-03-15 Epigenomics Ag Verfahren zur bestimmung der dna-methylierung in blut- oder urinproben
US20120196827A1 (en) 2006-06-12 2012-08-02 Oncomethylome Sciences S.A. Methylation markers for early detection and prognosis of colon cancers
GB0614567D0 (en) 2006-07-21 2006-08-30 Snell & Wilcox Ltd Motion vector interpolation
GB0700374D0 (en) * 2007-01-09 2007-02-14 Oncomethylome Sciences S A NDRG family methylation markers
WO2008100913A2 (en) 2007-02-12 2008-08-21 The Johns Hopkins University Early detection and prognosis of colon cancers
CN113897432A (zh) * 2014-12-12 2022-01-07 精密科学公司 用于进行甲基化检测测定的组合物和方法

Also Published As

Publication number Publication date
WO2008084219A1 (en) 2008-07-17
JP6141896B2 (ja) 2017-06-07
US11149317B2 (en) 2021-10-19
US10808286B2 (en) 2020-10-20
US20150240318A1 (en) 2015-08-27
WO2008084219A8 (en) 2008-12-18
US20250137070A1 (en) 2025-05-01
CN101680025A (zh) 2010-03-24
US9982308B2 (en) 2018-05-29
EP2650377A1 (en) 2013-10-16
JP2015154775A (ja) 2015-08-27
EP3434791A1 (en) 2019-01-30
US20190032149A1 (en) 2019-01-31
US20100144836A1 (en) 2010-06-10
EP2069527B1 (en) 2018-06-06
JP2010515448A (ja) 2010-05-13
EP2650377B1 (en) 2016-12-21
EP2069527A1 (en) 2009-06-17
US12215389B2 (en) 2025-02-04
EP3434791B1 (en) 2020-05-27
GB0700374D0 (en) 2007-02-14
CA2674988A1 (en) 2008-07-17
US20220064740A1 (en) 2022-03-03
JP5721950B2 (ja) 2015-05-20
US20180327859A1 (en) 2018-11-15
US8969046B2 (en) 2015-03-03

Similar Documents

Publication Publication Date Title
US12215389B2 (en) Compositions for detecting epigenetic modifications
US11634781B2 (en) Fecal sample processing and analysis comprising detection of blood
US10113202B2 (en) Method for determining the methylation status of the promoter region of the TWIST1 gene in genomic DNA from bladder cells
US20080221056A1 (en) Early Detection and Prognosis of Colon Cancers
US20170121775A1 (en) Detection and Prognosis of Lung Cancer
WO2013064163A1 (en) Methylation markers for colorectal cancer
WO2011135058A2 (en) Methods for detecting epigenetic modifications

Legal Events

Date Code Title Description
EEER Examination request
EEER Examination request

Effective date: 20120511

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 17TH ANNIV.) - STANDARD

Year of fee payment: 17

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250103

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250103